Skip to main content

Peer Review reports

From: The efficacy and safety of remdesivir alone and in combination with other drugs for the treatment of COVID-19: a systematic review and meta-analysis

Original Submission
10 Oct 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
20 Oct 2022 Reviewed Reviewer Report
21 Apr 2023 Reviewed Reviewer Report - Ricardo Ney Cobucci
22 Apr 2023 Reviewed Reviewer Report
23 Apr 2023 Reviewed Reviewer Report
27 May 2023 Author responded Author comments - Qianfeng Xia
Resubmission - Version 3
27 May 2023 Submitted Manuscript version 3
31 May 2023 Author responded Author comments - Qianfeng Xia
Resubmission - Version 4
31 May 2023 Submitted Manuscript version 4
1 Jun 2023 Reviewed Reviewer Report
1 Jun 2023 Reviewed Reviewer Report - Ricardo Ney Cobucci
10 Jun 2023 Reviewed Reviewer Report
20 Jul 2023 Reviewed Reviewer Report
31 Jul 2023 Author responded Author comments - Qianfeng Xia
Resubmission - Version 5
31 Jul 2023 Submitted Manuscript version 5
2 Aug 2023 Reviewed Reviewer Report
6 Aug 2023 Author responded Author comments - Qianfeng Xia
Resubmission - Version 6
6 Aug 2023 Submitted Manuscript version 6
Publishing
9 Aug 2023 Editorially accepted
9 Oct 2023 Article published 10.1186/s12879-023-08525-0

You can find further information about peer review here.

Back to article page